PM Modi should assure nation he won't allow 'buying MLAs off': Kapil Sibal

Agencies
May 19, 2018

New Delhi, May 19: Ahead of the crucial floor test in the Karnataka assembly, the Congress on Saturday asked Prime Minister Narendra Modi to assure the country that he would not encourage “buying MLAs off” as the BJP seeks to prove majority, and welcomed the assurance of live telecast of House proceedings.

The Congress said that every alleged attempt of the BJP to derail the vote of confidence stood “defeated” and asserted the "democracy will win".

Addressing reporters here, senior Congress leaders Kapil Sibal and Abhishek Manu Singhvi, who represented the Congress-JD(S) combine in the Supreme Court, said they did not press for the replacement of pro tem speaker K G Bopaiah after the assurance of live broadcast of the proceedings.

The Congress and the JD(S) had approached the apex court raising questions over the appointment of Bopaiah as the temporary speaker, contending he was not the senior most legislator.

It also maintained that Bopaiah had a "tainted past" as he as the then speaker had tried to save a previous government of Yeddyurappa, who faced corruption charges, in 2011.

Singhvi said whosoever wins or loses in the trust vote, it is the "democracy which will win".

Sibal also took a dig at Prime Minister Narendra Modi, saying "He (Modi) should also say 'na kharidunga, na kharidane dunga' (will neither buy off, nor let anyone be bought over)."

"The prime minister keeps saying 'na khaunga, na khane dunga' (will neither indulge in corruption nor allow it). He should also say 'na kharidunga, na kharidane dunga'," quipped Sibal.

There was no question of replacing the pro tem speaker when proceedings would be live telecast and transparency would be ensured, he added.

Asked about the BJP’s claim that the Supreme Court’s order was a blow for the Congress, Sibal countered it, suggesting that things were otherwise as the time period allowed for the BJP by Governor Vajubhai Vala was reduced from 15 days to 24 hours (which ends today).

Singhvi seconded Sibal, and added that the Supreme Court also said no to secret ballot and the pro tem speaker was disallowed to take any other agenda, suggesting the decision favoured the Congress-JD(S) combine.

"The achievement of our petition before the court is holding the trust vote in one-and-a-half days as against 15 days allowed earlier," he added.

Asked why did the Congress move the petition if it had to withdraw its pleas, Singhvi said the offer to hold live telecast was given only after our petition. He described the move of live telecast as “a virtue out of necessity".

Singhvi said, "We wanted safeguards to be in place on our apprehension. In a way most of our demands have been met."

Another senior leader of the party, P Chidambaram, saluted the apex court and added the live broadcast of the House proceedings would mean every citizen watching television “will be a pro tem speaker”.

“In Karnataka, what is at stake is not only who will form the Government, but who will be loyal to the electorate and uphold the verdict of his/her voters.

“Every trick of the BJP to delay or derail the vote of confidence has been defeated. Now, I am sure the Congress and JDS MLAs will defeat Mr Yeddyurappa,” he tweeted.

The Supreme Court today ordered live telecast of the floor test, which is scheduled for 4 pm.

"Live broadcast of floor test will be the best possible way to ensure transparency in the proceedings," a bench comprising justices A K Sikri, S A Bobde and Ashok Bhushan said.

The bench also made it clear that no other item in the agenda shall be taken up during the trust vote.

The bench said the secretary of the Legislative Assembly will record the proceedings of the House.

It said that several local channels will be provided the live feed of the proceedings so that they can also be in a position to telecast simultaneously.

The Supreme Court yesterday ordered a floor test in the Karnataka Assembly at 4 PM today, drastically slashing the 15-day window given by the Governor to BJP Chief Minister B S Yeddyurappa to prove majority.

The BJP has emerged as the single largest party with 104 seats, followed by the Congress with 78, JD(S) with 37 and three seats have gone to others in the 224-member Assembly where elections were held for 222 seats.

The majority mark is 112 seats and the post-poll alliance strength of the Congress-JD(S) combine, which claims to have 117 MLAs, has alleged foul play in the Governor inviting BJP to form the government.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 10,2020

New Delhi, Jun 10: Petrol price on Wednesday was hiked by 40 paise per litre and diesel by 45 paise, the fourth straight daily increase in rates after oil PSUs ended an 82-day hiatus in rate revision. Petrol price in Delhi was hiked to Rs 73.40 per litre from Rs 73, while diesel rates were increased to Rs 71.62 a litre from Rs 71.17, according to a price notification of state oil marketing companies.

Rates have been increased across the country and vary from state to state depending on the incidence of local sales tax or VAT.

This is the fourth daily increase in rates in a row since oil companies on Sunday restarted revising prices in line with costs, after ending an 82-day hiatus.

In four hikes, petrol price has gone up by Rs 2.14 per litre and diesel by Rs 2.23.

Latest petrol, diesel prices in top cities:

New Delhi: Petrol ₹73.40. Diesel ₹71.62

Gurgaon: Petrol ₹72.86. Diesel ₹64.90

Mumbai: Petrol ₹80.40. Diesel ₹70.35

Chennai: Petrol ₹77.43. Diesel ₹70.13

Hyderabad: Petrol ₹76.20. Diesel ₹70b

Bengaluru: Petrol ₹75.77. Diesel ₹68.09

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 19,2020

President Donald Trump gave a new justification for killing Qassim Suleimani, telling a gathering of Republican donors that the top Iranian general was "saying bad things about our country" before the strike, which led to his decision to authorise his killing. "How much are we going to listen to?" Trump said on Friday, according to remarks from a fundraiser obtained by CNN.

With his typical dramatic flourish, Trump recounted the scene as he monitored the strikes from the White House Situation Room when Suleimani was killed. The president spoke in a ballroom at his Mar-a-Lago club in Palm Beach, Florida, at a Republican event that raised $10 million for Trump's 2020 campaign.

The January 3 killing of Suleimani prompted Iran to retaliate with missile strikes against US forces in Iraq days later and almost triggered a broad war between the two countries. "They're together sir," Trump said military officials told him. "Sir, they have two minutes and 11 seconds. No emotion. Two minutes and 11 seconds to live, sir. They're in the car, they're in an armoured vehicle. Sir, they have approximately one minute to live, sir. Thirty seconds. Ten, 9, 8 ...'"

"Then all of a sudden, boom," he said. "They're gone, sir. Cutting off, I said, where is this guy?" Trump continued. "That was the last I heard from him". It was the most detailed account that Trump has given of the drone strike, which has drawn criticism from some US lawmakers because neither the president nor his advisers have provided public information to back up their statements that Suleimani presented an "imminent" threat to US.

Trump's comments came a day after he warned Iran's supreme leader Ayatollah Ali Khamenei to be "very careful with his words". According to Trump, Khamenei's speech on Friday, in which he attacked the "vicious" US and described UK, France and Germany as "America's lackeys", was a mistake.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.